Your browser doesn't support javascript.
loading
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
Stevens, Brett; Winters, Amanda; Gutman, Jonathan A; Fullerton, Aaron; Hemenway, Gregory; Schatz, Derek; Miltgen, Nicholas; Wei, Qi; Abbasi, Taher; Vali, Shireen; Singh, Neeraj K; Drusbosky, Leylah; Cogle, Christopher R; Hammes, Andrew; Abbott, Diana; Jordan, Craig T; Smith, Clayton; Pollyea, Daniel A.
Afiliação
  • Stevens B; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Winters A; University of Colorado Children's Hospital, Aurora CO, United States.
  • Gutman JA; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Fullerton A; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Hemenway G; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Schatz D; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Miltgen N; University of Colorado Children's Hospital, Aurora CO, United States.
  • Wei Q; University of Colorado Children's Hospital, Aurora CO, United States.
  • Abbasi T; Cellworks Group Inc, CA, United States.
  • Vali S; Cellworks Group Inc, CA, United States.
  • Singh NK; Cellworks Group Inc, CA, United States.
  • Drusbosky L; University of Florida, Gainesville FL, United States.
  • Cogle CR; University of Florida, Gainesville FL, United States.
  • Hammes A; Center for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado, Aurora, CO, United States.
  • Abbott D; Center for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado, Aurora, CO, United States.
  • Jordan CT; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Smith C; University of Colorado Division of Hematology, Aurora, CO, United States.
  • Pollyea DA; University of Colorado Division of Hematology, Aurora, CO, United States. Electronic address: Daniel.pollyea@ucdenver.edu.
Leuk Res ; 81: 43-49, 2019 06.
Article em En | MEDLINE | ID: mdl-31009835
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Biologia Computacional / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Biologia Computacional / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos